Biocryst Pharmaceuticals Inc.
NASDAQ:BCRX
| Market Cap (Intraday) | 1.71B |
| Current PE | N/A |
| Forward PE | 83.1 |
| 2yr Forward PE | 14.84 |
| 10-Day MA | $8.43 |
| 50-Day MA | $8.69 |
| 200-Day MA | $8.46 |
Biocryst Pharmaceuticals Inc. Stock, NASDAQ:BCRX
4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8457
United States of America
Phone: +1.919.859.1302
Number of Employees: 580
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.